BIRTH OF A CANCER DRUG - In 1980, American doctor John Mendelsohn tried to interest someone--anyone--in a treatment he created to stop cancer growth. Twelve years later, he found a believer in ImClone Systems, and then had to watch as the biotech startup struggled to raise development money. Now, after more than 20 years and a constant quest for funding, IMC-C225 looks promising and is awaiting ...
Year of publication:
Business week : BW. - New York, NY : McGraw-Hill, ISSN 0007-7135, ZDB-ID 2402762. - 2001 (30.07.), p. 46-53